Table 2. The contents of serum total protein, and GOT and GPT of mice fed PSW and LPSW
Treatment1) | Total protein (g/dL) | GOT (IU/dL) | GPT (IU/dL) |
CON | 5.97±0.088b | 105.33±3.712d | 32.67±4.910 |
SCO | 5.97±0.033b | 137.00±4.041bc | 31.67±2.404 |
THA10 | 6.47±0.120a | 166.67±0.882a | 33.00±1.000 |
PSW10 | 6.30±0.153ab | 172.33±13.445a | 35.67±1.667 |
PSW40 | 6.43±0.033a | 148.67±16.374ab | 31.00±2.082 |
LPSW100 | 6.23±0.033ab | 130.00±1.528bcd | 29.00±2.082 |
LPSW400 | 6.13±0.203ab | 118.00±7.550cd | 30.00±1.528 |
All values are mean±SE.
Means within same column with different letter differ significantly (p<0.05).
Control (CON); scopolamine (SCO, 1 mg/kg body weight (B.W.), intraperitoneally (i.p.); tetrahydroaminoacridine 10 [THA 10, tacrine; 10 mg/kg B.W. per oral (p.o.) with SCO (i.p.)]; pig skin water extracts [PSW 10, 10 mg/kg B.W. (p.o.) with SCO (i.p.)]; PSW 40 [40 mg/kg B.W. (p.o.) with SCO (i.p.)]; low molecular weight pig skin water extracts [LPSW 100, 100 mg/kg B.W. (p.o.) with SCO (i.p.)]; LPSW 400 [400 mg/kg B.W. (p.o.) with SCO (i.p.)].
GOT, glutamic oxaloacetic transaminase; GPT, glutamic pyruvic transaminase.